European Patent Office

T 0970/17 of 14.10.2021

European Case Law Identifier
ECLI:EP:BA:2021:T097017.20211014
Date of decision
14 October 2021
Case number
T 0970/17
Petition for review of
-
Application number
10183394.5
Language of proceedings
English
Distribution
Distributed to board chairmen (C)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
Infusion apparatuses and related methods
Applicant name
C.R. Bard, Inc.
Opponent name
Smiths Medical ASD, Inc.
Board
3.2.02
Headnote
-
Keywords
Admissibility of appeal - (yes)
Admittance of claim requests - (yes / no)
Admittance of documents filed in appeal - (yes / no)
Amendments - extension beyond the content of the parent application as filed
Amendments - (no)
Amendments - extension beyond the content of the application as filed
Amendments - (no)
Amendments - extension of the scope of the patent ("aliud")
Amendments - (no)
Novelty - (yes, after amendment)
Inventive step - (yes)
Sufficiency of disclosure - (yes)
Late-filed objection - admitted
Late-filed objection - (no)
Referral to the Enlarged Board of Appeal - (no)
Apportionment of costs - (no)
Catchword
Assessing compliance with Article 123(3) EPC does not include a test taking into account national infringement laws such as the rules on contributory infringement (point 6.2 of the Reasons).
Citing cases
T 0321/21

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the opposition division with the order to maintain the patent as amended in the following version:

- claims 1-17 according to the third auxiliary request filed with the proprietor's statement of grounds of appeal

- description paragraphs [0001]-[0008] and [0010]-[0141] of the patent specification and paragraph [0009] as filed during the oral proceedings before the board on 14 October 2021

- Figures 1-59 of the patent specification

3. The opponent's request for referral to the Enlarged Board of Appeal is refused.

4. The proprietor's request for apportionment of costs is refused.